About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT04947683

Patient Journey With Advanced Lung Cancer Positive for ALK Fusion in Brazil

Observational, retrospective cohort study that will include patients diagnosed with NSCLC and ALK rearrangement between January 2015 and December 2020.

Lead sponsor: Latin American Cooperative Oncology Group•5 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Latin American Cooperative Oncology Group

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients older than 18 years;
•Newly diagnosed advanced stage IIIB-IV NSCLC (AJCC 8th edition) or locally advance/distant relapse in the period of January 2015 to December 2020.
•NSCLC with pathological confirmation of ALK rearrangement by immunohistochemistry, fluorescent in situ hybridization (FISH) or next generation sequencing (NGS);
•ECOG 0-4;
•Patients with CNS metastases are also considered eligible, regardless of the initial treatment instituted.

Exclusion Criteria

•\- Incomplete medical chart in terms of date of diagnosis, ALK test results and outcomes

Related studies

RECRUITINGPhase 2

A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)

NCT06780085 · Carcinoma, Non-Small-Cell Lung

RECRUITINGPhase 2

Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC

NCT07489066 · Carcinoma, Non-Small-Cell Lung, and more

A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

NCT07230691 · Carcinoma, Non-Small-Cell Lung

RECRUITINGPhase 1/2

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer

NCT06380816 · Advanced Solid Tumours, Squamous Cell Carcinoma of Head and Neck, and more

RECRUITINGPhase 2

A Study of BMS-986504 in Participants With Pre-treated Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC) With Homozygous MTAP Deletion (MountainTAP-9)

NCT06855771 · Carcinoma, Non-Small-Cell Lung

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 2, 2023Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment101

Start dateApr 2020

Last updatedAug 2, 2023

Condition

Carcinoma, Non-Small-Cell Lung

Locations shown

Centro Regional Integrado de Oncologia (CRIO)

Fortaleza, Ceará

Instituto D'OR

Rio de Janeiro, Rio de Janeiro

Liga Norte Riograndense Contra o Câncer

Natal, Rio Grande do Norte

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 2, 2023Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions